Treatment of T2DM Patients in Germany receiving Empagliflozin: A retrospective RWE Study Description of Treatment and Population Characteristics of Type 2 Diabetic Patients in Germany receiving Empagliflozin: A retrospective Real-World Evidence (RWE) study based on German registries DPV&DIVE

ENCePP Code of conduct

No information provided.

Data sources

• Data sources (types):
  Disease registry

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  Unknown

Procedures

No information provided.